Clinical Trials, Drug Manufacturers

Micromeritics’ Solutions Identify and Control Critical Quality Attributes

By Micromeritics

Quality by design (QbD) is a developmental approach, which predefines objectives and emphasises understanding of product s and process control from science and quality risk management.

Achieving QbD requires an in depth understanding of psychochemical properties, which predict processability, in vivo, and in vitrio performance. Early identification of critical quality attributes (CQA) of excipients and active pharmaceutical ingredients (API) and their impact on a formulation is a key component of QbD.

Micromeritics' Instruments and contract analytical services offers solutions for the early identification of CQAs, continuous process monitoring, and verification, which are the foundations of QbD.

Download to find out more.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.